These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 6753887)

  • 21. Suppression of ventricular arrhythmias with intravenous disopyramide and lidocaine: efficacy comparison in a randomized trial.
    Sbarbaro JA; Rawling DA; Fozzard HA
    Am J Cardiol; 1979 Sep; 44(3):513-20. PubMed ID: 474432
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Clinical studies of the antiarrhythmic efficacy of disopyramide phosphate (Norpace) (author's transl)].
    Smith WS
    Herz; 1978 Dec; 63(36):399-406. PubMed ID: 95482
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oral disopyramide after admission to hospital with suspected acute myocardial infarction. U. K. Rythmodan Multicentre Study Group.
    Postgrad Med J; 1984 Feb; 60(700):98-107. PubMed ID: 6369290
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of disopyramide phosphate on ventricular arrhythmias in experimental myocardial infarction.
    Kus T; Sasyniuk BI
    J Pharmacol Exp Ther; 1976 Mar; 196(3):665-75. PubMed ID: 1263118
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Disopyramide and mexiletine: which is the agent of choice in the long term-oral treatment of lidocaine-responsive arrhythmias? Efficacy comparison in a randomized trial.
    Trimarco B; Volpe M; Ricciardelli B; Sacca' L; De Luca N; Rengo F; Condorelli M
    Arch Int Pharmacodyn Ther; 1980 Dec; 248(2):251-9. PubMed ID: 7013721
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of disopyramide after myocardial infarction.
    Jones MB
    Bristol Med Chir J; 1976; 91(339-340):12. PubMed ID: 802388
    [No Abstract]   [Full Text] [Related]  

  • 27. Disopyramide in the treatment and prevention of arrhythmias following myocardial infarction.
    Zainal N; Jennings G; Jones B; Model D; Turner P; Besterman EM; Kidner PH
    J Int Med Res; 1976; 4(1 Suppl):71-3. PubMed ID: 799982
    [No Abstract]   [Full Text] [Related]  

  • 28. Efficacy of intravenous disopyramide in acute cardiac arrhythmias.
    De Backer M; Stoupel E; Kahn RJ
    Eur J Clin Pharmacol; 1981 Jan; 19(1):11-8. PubMed ID: 6161824
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The use of disopyramide in resistant cardiac arrhythmias due to acute ischaemic heart disease.
    Sandler G
    J Int Med Res; 1977; 5(5):369-73. PubMed ID: 913864
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The antiarrhythmic effect of intravenous disopyramide in an open study.
    Tonkin AM; Heddle WF; Bett JH; Kemp RJ; Donnelly GL; Nelson GI; Manolas E; Sloman JG
    Aust N Z J Med; 1982 Aug; 12(4):271-5. PubMed ID: 6958238
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mexiletine in the prophylaxis of ventricular arrhythmias during acute myocardial infarction.
    Campbell RW; Achuff SC; Pottage A; Murray A; Prescott LF; Julian DG
    J Cardiovasc Pharmacol; 1979; 1(1):43-52. PubMed ID: 94381
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects on ventricular arrhythmias of oral captopril and of oral mononitrate started early in acute myocardial infarction: results of a randomised placebo controlled trial.
    Pipilis A; Flather M; Collins R; Hargreaves A; Kolettis T; Boon N; Foster C; Appleby P; Sleight P
    Br Heart J; 1993 Feb; 69(2):161-5. PubMed ID: 7679583
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Disopyramide in myocardial infarction.
    Lancet; 1977 Dec; 2(8049):1185-6. PubMed ID: 73103
    [No Abstract]   [Full Text] [Related]  

  • 34. Comparison of the efficacy of propafenone versus disopyramide for complex premature ventricular contractions. Evaluation with long-term monitoring.
    Naccarella F; Palmieri M; del Corso P; Lombardi G; Bracchetti D
    Arzneimittelforschung; 1982; 32(5):547-50. PubMed ID: 7201833
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy of disopyramide phosphate in the treatment of refractory ventricular tachycardia.
    Vismara LA; Vera Z; Miller RR; Mason DT
    Am J Cardiol; 1977 Jun; 39(7):1027-34. PubMed ID: 326016
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of low oral doses of disopyramide and amiodarone on ventricular and atrial arrhythmias of chagasic patients with advanced myocardial damage.
    Carrasco HA; Vicuña AV; Molina C; Landaeta A; Reynosa J; Vicuña N; Fuenmayor A; López F
    Int J Cardiol; 1985 Dec; 9(4):425-38. PubMed ID: 3908329
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lidocaine prophylaxis for fatal ventricular arrhythmias after acute myocardial infarction.
    Pharand C; Kluger J; O'Rangers E; Ujhelyi M; Fisher J; Chow M
    Clin Pharmacol Ther; 1995 Apr; 57(4):471-8. PubMed ID: 7712677
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical evaluation of antiarrhythmic effects of disopyramide by multiclinical controlled double-blind methods.
    Kimura E; Mashima S; Tanaka T
    Int J Clin Pharmacol Ther Toxicol; 1980; 18(8):338-43. PubMed ID: 7409935
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Disopyramide: a review of its pharmacological properties and therapeutic use in treating cardiac arrhythmias.
    Heel RC; Brogden RN; Speight TM; Avery GS
    Drugs; 1978 May; 15(5):331-68. PubMed ID: 350555
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Plasma levels of disopyramide after administration of conventional capsules and sustained-release tablets.
    Nauta IL; van de Calseyde J; Hertzberger DP
    Curr Med Res Opin; 1983; 8(8):582-93. PubMed ID: 6653136
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.